招商証券(06099.HK)附屬終止以5億人幣收購杭州招盈股權
招商証券(06099.HK)去年公布,全資附屬招商證券投資與招商局地產(杭州)及杭州招盈訂立杭州合作框架協議,招商證券投資同意向其收購杭州招盈的24%股權,代價最多為5億元人民幣(下同)。另外招商證券投資與珠海依雲及長沙仁惠訂立長沙合作框架協議,招商證券投資同意向其收購長沙仁惠約18.4%股權,代價最多為3億元。
公司公布,受市場環境影響,招商證券投資與招商局地產(杭州)預期難以在期間內就建議杭州收購事項達成最終正式合作協議,經公平磋商後均同意終止建議杭州收購事項。現時招商證券投資與珠海依雲仍在就收購事項進行磋商及討論,以期在相關期間內達成最終正式合作協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.